Exposing drug industry funding of UK patient organisationsBMJ 2019; 365 doi: https://doi.org/10.1136/bmj.l2365 (Published 03 June 2019) Cite this as: BMJ 2019;365:l2365
The “Who received funding?” section of this analysis by Ozieranski and colleagues (BMJ 2019;365:l1806, doi:10.1136/bmj.l1806) contained a typographical error. It should have read that “Most funding (£47 466 806, 82.8%) went to 314 multipurpose organisations . . .” rather than 31. This has been corrected on bmj.com.
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.